Latest in Why the investor craze for Ozempic and rival weight loss drugs may resume next year
Sort by
1,513 items
-
Why the investor craze for Ozempic and rival weight-loss drugs may resume next year
Novo Nordisk’s takeover of Catalent and the Danish firm’s push to launch a new generation of drugs could boost the importance of GLP agonists in 2025, Barclays analysts saidMarketWatch - 6h -
Ether may finally rise to record high next year, after lagging behind bitcoin
While ether has been lagging behind bitcoin, the second-largest crypto by market capitalization could hit a record high above $5,000 next year if its current demand-and-supply dynamics continue, ...MarketWatch - 22h -
This hasn’t happened to U.S. stocks in more than 20 years — here’s why investors should be concerned
The U.S. stock market is suffering from another bout of “bad breadth.”MarketWatch - 2d -
Why are investors excited about Trump's upcoming term?
President-elect Donald Trump returned to his hometown of New York City on Thursday to ring the opening bell at the New York Stock Exchange. Wall Street investors seem to have embraced the incoming ...CBS News - 3d -
In shift, RFK Jr. now says weight-loss drugs 'have a place'
His remarks come days before he holds confirmation meetings with GOP senators.ABC News - 3d -
Elon Musk contradicts RFK Jr.'s sentiments on weight loss drugs
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.ABC News - 4d -
Finally, there’s a strategist who expects the stock market to fall next year – here’s why
Stubborn inflation and a slowing economy will cause the S&P 500 to decline next year, one strategist forecasts.MarketWatch - 4d -
UN drug experts say opium production has leveled off in Myanmar, but instability may trigger a rise
U.N. experts say there has been a slight drop in the production of opium in Myanmar, the world’s biggest source of the illicit drug from which heroin is derived, but warn there are still strong ...ABC News - 4d -
Nasdaq reaches 20,000 for the first time. Why that could spell trouble for investors in early 2025.
Stock investors could take profits, or stick with what’s worked well in the past.MarketWatch - 4d -
What other conditions could weight-loss drugs treat?
Initial research has focused on obesity, but Ozempic, Wegovy and Mounjaro may potentially be used for addiction, heart disease and Alzheimer’sFinancial Times - 4d -
Quantum-computing stocks are soaring as investors place bets on ‘the next big thing’ in tech
A trio of quantum-computing stocks have seen huge gains over the past few months, bolstered by a wave of hype from retail investors looking to cash in on what could be the next big thing in tech.MarketWatch - 5d -
Why Cathie Wood may have the best fund to play Trump 2.0
Exposure to crypto, Musk and defense is bolstering this ETFMarketWatch - 5d -
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
It is made possible through a first-of-a-kind integration with Eli Lilly's direct-to-consumer website, and aims to streamline access to the popular treatment.CNBC - 5d -
Investors may face a major inflation surprise next year. How pros are preparing.
Big investment managers like Nuveen are factoring in the possibility that their base-case expectations for a soft landing, accompanied by easing inflation, might turn out to be wrong.MarketWatch - 6d -
Some health experts warn against microdosing weight loss drugs
The demand for weight loss drugs, like Ozempic and Wegovy, has skyrocketed in the past few years despite the high cost and unpleasant side effects for some people. The New York Times reports some ...CBS News - 6d -
Mondelez is reportedly exploring a Hershey acquisition. Drugs like Ozempic could justify a deal.
Shares of Hershey Co. booked a double-digit percentage gain on Monday after Bloomberg reported that Oreo maker Mondelez International Inc. was exploring a possible acquisition of the iconic ...MarketWatch - 6d -
The switch from speculative stocks to highly speculative stocks may see these investors get burned
There are pockets of the market very vulnerable to a dip in risk appetite, says Vanda ResearchMarketWatch - Dec. 9 -
The weight-loss drug boom has become one of the internet's biggest scams
As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according to cybersecurity experts.CNBC - Dec. 8 -
Fentanyl may enter the US from Mexico, but the drug of choice there is different
Use of crystal meth is soaring among workers, partiers and the young and threatening a public health crisis. All night, Daniela stares at screens in the warehouse where she works as a security ...The Guardian - Dec. 8 -
If McGregor fights it will be sometime next year - White
UFC president Dana White says if Conor McGregor fights again in the promotion it "will be sometime next year".Yahoo Sports - Dec. 8 -
Ernst and Hegseth to resume meetings next week
Sen. Joni Ernst (R-Iowa) said she will meet with Secretary of Defense nominee Pete Hegseth again next week as he continues to pitch himself to lawmakers on Capitol Hill. “Pete Hegseth and I will ...The Hill - Dec. 7 -
Why TikTok Faces a U.S. Ban, and What’s Next?
The short-form video app lost a challenge to a law that will ban TikTok in the United States if its owner, ByteDance, does not sell to a non-Chinese company. It has pledged to appeal to the Supreme ...The New York Times - Dec. 6 -
The stock market’s ‘fear gauge’ is trading at lows. Why retail investors should take note.
The Cboe Volatility Index hasn’t been this low in months.MarketWatch - Dec. 6 -
Weight-loss drug Mounjaro 'changed my life,' says mother-of-two
People struggling with their weight welcome the NHS rollout of Mounjaro but worry about delays.BBC News - Dec. 5 -
The Allure of ‘Microdosing’ Ozempic
Some people are taking tiny amounts of weight loss medications, hoping to drop pounds while avoiding side effects. Does it work?The New York Times - Dec. 5 -
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk's Wegovy and Eli Lilly's Zepbound.CNBC - Dec. 5 -
Legendary drug lord released after serving 25 years in U.S. prison
Fabio Ochoa Vásquez and his brothers amassed a fortune when cocaine started flooding the U.S. in the late 1970s and early 1980s.CBS News - Dec. 5 -
World’s biggest hedge fund flags the ‘holy grail’ that may shield investors if U.S. stock rally crumbles
Karen Karniol-Tambour, co-chief investment officer at Bridgewater Associates, says valuations are much higher for U.S. stocks than they were when the bull run began.MarketWatch - Dec. 5 -
Millions will have to wait up to 12 years for NHS weight-loss drug
Fears that giving 3.4 million people immediate access to new weight-loss drug could overwhelm NHS.BBC News - Dec. 5 -
Will Trump nix Biden’s coverage plan for weight-loss drugs? It’ll be a close call.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says it’s possible he could end up supporting the Democratic incumbent’s ...MarketWatch - Dec. 4 -
Zepbound brings more weight loss than Wegovy: Drugmaker
Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical trial results. Zepound manufacturer Eli Lilly released results from their ...The Hill - Dec. 4 -
Eli Lilly's obesity drug beats rival in head-to-head trial — where Cramer sees shares going next
New trial data has cemented Club holding Eli Lilly's pole position in the highly competitive weight loss drug race.CNBC - Dec. 4 -
Eli Lilly says Zepbound’s weight-loss results beat those of rival Wegovy
Zepbound helped patients lose more weight than a major rival in a head-to-head trial.MarketWatch - Dec. 4 -
Investors' crypto donations to charity skyrocket. Why it can be 'hugely beneficial,' expert says
There's soaring interest in donating crypto to charity, according to Fidelity Charitable. Here's how those donations can pay off at tax time.CNBC - Dec. 4 -
A rival weight loss drug to Wegovy helped people shed more pounds, study shows
People who took Zepbound, Eli Lilly’s weight loss drug, shed more pounds than those on Novo Nordisk’s Wegovy in a clinical trial, Lilly said in a release Wednesday.NBC News - Dec. 4 -
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Zepbound's greater weight loss is a huge advantage for Eli Lilly, which is competing with Novo Nordisk for a larger share of the weight loss drug market.CNBC - Dec. 4 -
Talks on a new NHL CBA are set to start early next year. Here's why there is optimism
Talks on a new collective bargaining agreement between the NHL and NHL Players' Association are set to begin in early 2025ABC News - Dec. 3 -
Experts create controllable gastric balloon to aid weight loss
Device inflates before eating and contracts afterwards, simulating the effects of having a meal, say scientists. From weight loss jabs to vibrating pills , the obesity crisis has spawned myriad ...The Guardian - Dec. 3 -
Next Game Pass Release Is A Crash Bandicoot Kart Racer, And That May Not Be All
The calendar has flipped over to December, and while Microsoft isn't ready to reveal all the games headed to Game Pass this month, the company has announced one: Crash Team Racing Nitro-Fueled. The ...GameSpot - Dec. 3 -
Why America’s economy is soaring ahead of its rivals
The country’s outperformance is rooted in long-term productivity growth that is the envy of the developed world. Could Trump’s policies endanger its lead?Financial Times - Dec. 3
